A phase II study of vorinostat (MK-0683) in patients with polycythaemia vera and essential thrombocythaemia-Reference-Cited by-同舟云学术

A phase II study of vorinostat (MK-0683) in patients with polycythaemia vera and essential thrombocythaemia

Published:2013-06-11 Issue:4 Volume:162 Page:498-508
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Andersen Christen L.,McMullin Mary F.¹,Ejerblad Elisabeth²,Zweegman Sonja³,Harrison Claire⁴,Fernandes Savio⁵,Bareford David⁵,Knapper Steven⁶,Samuelsson Jan⁷,Löfvenberg Eva⁸,Linder Olle⁹,Andreasson Bjørn¹⁰,Ahlstrand Erik⁹,Jensen Morten K.¹¹,Bjerrum Ole W.¹²,Vestergaard Hanne¹³,Larsen Herdis¹⁴,Klausen Tobias W.¹¹,Mourits-Andersen Torben¹⁵,Hasselbalch Hans C.¹⁶

Affiliation:

1. Department of Haematology; Queen′s University Belfast; Belfast; UK

2. Department of Haematology; Uppsala University Hospital; Uppsala; Sweden

3. Department of Haematology; VU University Medical Centre; Amsterdam; The Netherlands

4. Department of Haematology; Guy's and St Thomas; NHS Foundation Trust; London; UK

5. Department of Haematology; Russells Hall Hospital; Dudley; UK

6. Department of Haematology; Cardiff University; Cardiff; UK

7. Department of Internal Medicine; Stockholm South Hospital; Stockholm; Sweden

8. Haematology Centre; Karolinska University Hospital; Stockholm; Sweden

9. Division of Haematology; Department of Medicine; Örebro University Hospital; Örebro; Sweden

10. Department of Haematology; Uddevalla Hospital; NU Hospital Organization; Uddevalla; Sweden

11. Department of Haematology; Herlev Hospital; Herlev; Denmark

12. Department of Haematology; Copenhagen University Hospital; Rigshospitalet; Copenhagen; UK

13. Department of Haematology; Odense University Hospital; Odense; Denmark

14. Department of Internal Medicine, (Haematological Department); Viborg Hospital; Viborg; Denmark

15. Department of Haematology; Esbjerg Hospital; Esbjerg; Denmark

16. Department of Haematology; Roskilde Hospital; Roskilde; Denmark

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12416/fullpdf

Reference30 articles.

1. Efficacy of vorinostat in a murine model of polycythemia vera;Akada;Blood,2012

2. Symptom Burden Among PV and ET Patients Receiving A Novel Histone Deacetylase Inhibitor: Findings From a Open-Label Phase II Study;Andersen;Blood,2012

3. Selective growth inhibition of tumor cells by a novel histone deacetylase inhibitor, NVP-LAQ824;Atadja;Cancer Research,2004

4. Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference;Barosi;Blood,2009

5. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders;Baxter;Lancet,2005

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polycythemia Vera: Barriers to and Strategies for Optimal Management;Blood and Lymphatic Cancer: Targets and Therapy;2023-12

2. Hydroxamic Acids Containing a Bicyclic Pinane Backbone as Epigenetic and Metabolic Regulators: Synergizing Agents to Overcome Cisplatin Resistance;Cancers;2023-10-14

3. Epigenetics in myeloproliferative neoplasms;Frontiers in Oncology;2023-07-13

4. Treatment Algorithm of Essential Thrombocythemia;Pathogenesis and Treatment of Leukemia;2023

5. Pharmacological Modulation of the Crosstalk between Aberrant Janus Kinase Signaling and Epigenetic Modifiers of the Histone Deacetylase Family to Treat Cancer;Pharmacological Reviews;2022-12-08